The Clinical Trial Company rmed by Ewan Campbell and Kerri Leeming, both previously senior level personnel within the clinical research sector. They realised there was an opportunity in the CRO sector for a company which targeted medium size clinical trials and novel products which lacked a classical road map to the market.
Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as Orphan drug and biologics.
The CLINICAL TRIAL Company™ employs are large numbers of people from successful biotech’s who understand how to bring novel products to market. Where possible, traditional “one size fits all” lengthy approval routes are replaced with pragmatic real-life planning without risk to long term success.
Its Directors and experienced management team offer comprehensive client-side experience to you the customer. This offering appeals to people unhappy with delays caused by conventional off-the-shelf approval strategies which ignore the unique nature of each product and market.
The company enjoys an open and enthusiastic culture which results in maximum personal motivation. Staff are flexible and embrace new challenges. Continuous cross-fertilisation across disciplines is encouraged, resulting in high levels of personal job satisfaction.
The Company operates an ISO 9001:2008 Quality Management System and was a recipient this year of the Queen’s Award for Enterprise.
The Clinical Trial Company (TCTC) is a Contract Research Organization with experience in the development of products from preclinical, through Phase I healthy volunteers studies, to clinical Phase II-IV patient and post-marketing studies.
TCTC’s highly-trained employees have a wealth of experience in clinical development and an extensive knowledge of both the regulatory and clinical trial requirements for Pharmaceutical, Biological and Medical Device products across a wide range of therapeutic areas and indications. TCTC also have amongst the team a Qualified Person for Investigational Medicinal Products, [QP (IMP)], to assist with the drug certification process for IMPs within the European Union.
From our offices in Canada, Australia and the UK and through an established network of providers, we are able to offer full-service clinical trials, to you, throughout North America, Europe, Asia and Africa.
Medical Writing & Reporting
In addition to full-service clinical studies, TCTC Group provides, for you, stand-alone services including Project Management, Clinical Monitoring, Regulatory, Quality Assurance and Strategic Development Consultancy.
TCTC Group staff are also available to join your clinical team on a contractual basis from periods of a few days to more than a year and either on a part-time or full-time basis through The CRA Company (www.thecracompany.com).
TCTC’s organic growth has been based on customer loyalty and its highly trained staff’s quality, flexibility, communication and motivation are reflected in a high level of repeat business from clients throughout the world.
Contact us today to find out how we can add value to your organization.
The CLINICAL TRIAL Company ....... We’re here to help you
Last Updated: 04-27-2012